APO Research

APO RESEARCH · REPORT

Melphalan Injection

Selected research

Industry Growth & Trends

Global Melphalan Injection Industry Growth and Trends Forecast to 2032

Market perspective

The global Melphalan Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Melphalan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Melphalan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Melphalan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Melphalan Injection include Athenex, Dr. Reddy's, Mediclone Biotech, Meitheal Pharmaceutical, Par Pharmaceuticals, Sagent, Spectrum Pharmaceuticals, Fresenius Kabi and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Melphalan Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Melphalan Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Melphalan Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Melphalan Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Melphalan Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Melphalan Injection Market by Company

Athenex

Dr. Reddy's

Mediclone Biotech

Meitheal Pharmaceutical

Par Pharmaceuticals

Sagent

Spectrum Pharmaceuticals

Fresenius Kabi

GSK

Mylan

Melphalan Injection Segment by Type

50mg/vial

10mg/vial

Melphalan Injection Segment by Application

Recovery Center

Hospital

Clinics

Melphalan Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melphalan Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melphalan Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melphalan Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Melphalan Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Melphalan Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50mg/vial Table 2. Major Company of 10mg/vial Table 3. Global Melphalan Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Melphalan Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Melphalan Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Melphalan Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Melphalan Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Melphalan Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Melphalan Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Melphalan Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Melphalan Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Melphalan Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Melphalan Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Melphalan Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Melphalan Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Melphalan Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Melphalan Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Melphalan Injection Industry Trends Table 25. Melphalan Injection Industry Drivers Table 26. Melphalan Injection Industry Opportunities and Challenges Table 27. Melphalan Injection Industry Restraints Table 28. Global Melphalan Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Melphalan Injection Revenue Market Share by Company (2021-2026) Table 30. Global Melphalan Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Melphalan Injection Sales Share by Company (2021-2026) Table 32. Global Melphalan Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Melphalan Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Melphalan Injection Major Company Production Sites and Headquarters Table 35. Global Melphalan Injection Company, Product Type & Application Table 36. Global Melphalan Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Melphalan Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Melphalan Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Melphalan Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Melphalan Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Melphalan Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Melphalan Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Melphalan Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Melphalan Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Melphalan Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Melphalan Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Melphalan Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Melphalan Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Melphalan Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Melphalan Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Melphalan Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Melphalan Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Melphalan Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Melphalan Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Melphalan Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Melphalan Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Melphalan Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Melphalan Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Melphalan Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Melphalan Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Melphalan Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Melphalan Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Melphalan Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Athenex Company Information Table 72. Athenex Business Overview Table 73. Athenex Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Athenex Melphalan Injection Product Portfolio Table 75. Athenex Recent Development Table 76. Dr. Reddy's Company Information Table 77. Dr. Reddy's Business Overview Table 78. Dr. Reddy's Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Dr. Reddy's Melphalan Injection Product Portfolio Table 80. Dr. Reddy's Recent Development Table 81. Mediclone Biotech Company Information Table 82. Mediclone Biotech Business Overview Table 83. Mediclone Biotech Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Mediclone Biotech Melphalan Injection Product Portfolio Table 85. Mediclone Biotech Recent Development Table 86. Meitheal Pharmaceutical Company Information Table 87. Meitheal Pharmaceutical Business Overview Table 88. Meitheal Pharmaceutical Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Meitheal Pharmaceutical Melphalan Injection Product Portfolio Table 90. Meitheal Pharmaceutical Recent Development Table 91. Par Pharmaceuticals Company Information Table 92. Par Pharmaceuticals Business Overview Table 93. Par Pharmaceuticals Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Par Pharmaceuticals Melphalan Injection Product Portfolio Table 95. Par Pharmaceuticals Recent Development Table 96. Sagent Company Information Table 97. Sagent Business Overview Table 98. Sagent Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sagent Melphalan Injection Product Portfolio Table 100. Sagent Recent Development Table 101. Spectrum Pharmaceuticals Company Information Table 102. Spectrum Pharmaceuticals Business Overview Table 103. Spectrum Pharmaceuticals Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Spectrum Pharmaceuticals Melphalan Injection Product Portfolio Table 105. Spectrum Pharmaceuticals Recent Development Table 106. Fresenius Kabi Company Information Table 107. Fresenius Kabi Business Overview Table 108. Fresenius Kabi Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Fresenius Kabi Melphalan Injection Product Portfolio Table 110. Fresenius Kabi Recent Development Table 111. GSK Company Information Table 112. GSK Business Overview Table 113. GSK Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. GSK Melphalan Injection Product Portfolio Table 115. GSK Recent Development Table 116. Mylan Company Information Table 117. Mylan Business Overview Table 118. Mylan Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Mylan Melphalan Injection Product Portfolio Table 120. Mylan Recent Development Table 121. North America Melphalan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 123. North America Melphalan Injection Sales Market Share by Country (2021-2026) Table 124. North America Melphalan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Melphalan Injection Sales Market Share Forecast by Country (2027-2032) Table 126. North America Melphalan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Melphalan Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Melphalan Injection Market Share by Country (2021-2026) Table 129. North America Melphalan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Melphalan Injection Market Share Forecast by Country (2027-2032) Table 131. Europe Melphalan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 133. Europe Melphalan Injection Sales Market Share by Country (2021-2026) Table 134. Europe Melphalan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Melphalan Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Melphalan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Melphalan Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Melphalan Injection Market Share by Country (2021-2026) Table 139. Europe Melphalan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Melphalan Injection Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Melphalan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Melphalan Injection Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Melphalan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Melphalan Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Melphalan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Melphalan Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Melphalan Injection Market Share by Country (2021-2026) Table 149. Asia-Pacific Melphalan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Melphalan Injection Market Share Forecast by Country (2027-2032) Table 151. Latin America Melphalan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 153. Latin America Melphalan Injection Sales Market Share by Country (2021-2026) Table 154. Latin America Melphalan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Melphalan Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Melphalan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Melphalan Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Melphalan Injection Market Share by Country (2021-2026) Table 159. Latin America Melphalan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Melphalan Injection Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Melphalan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Melphalan Injection Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Melphalan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Melphalan Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Melphalan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Melphalan Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Melphalan Injection Market Share by Country (2021-2026) Table 169. Middle East and Africa Melphalan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Melphalan Injection Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Melphalan Injection Distributors List Table 174. Melphalan Injection Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Melphalan Injection Image Figure 2. Global Melphalan Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melphalan Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Melphalan Injection Sales (2021-2032) & (K Units) Figure 5. 50mg/vial Image Figure 6. Global 50mg/vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10mg/vial Image Figure 8. Global 10mg/vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Melphalan Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Melphalan Injection Market Share by Type 2025 VS 2032 Figure 11. North America Melphalan Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Melphalan Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Melphalan Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Melphalan Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Melphalan Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Melphalan Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Melphalan Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Melphalan Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Melphalan Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Melphalan Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Melphalan Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Recovery Center Image Figure 24. Global Recovery Center Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Melphalan Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Melphalan Injection Market Share by Application 2025 VS 2032 Figure 31. North America Melphalan Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Melphalan Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Melphalan Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Melphalan Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Melphalan Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Melphalan Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Melphalan Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Melphalan Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Melphalan Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Melphalan Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Melphalan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Melphalan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Melphalan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Melphalan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Melphalan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Melphalan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Melphalan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Melphalan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Melphalan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Melphalan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Melphalan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Melphalan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Melphalan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Melphalan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Melphalan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Melphalan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Melphalan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Melphalan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Melphalan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Melphalan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Melphalan Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Melphalan Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg/vial
  • 10mg/vial
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • Athenex
  • Dr. Reddy's
  • Mediclone Biotech
  • Meitheal Pharmaceutical
  • Par Pharmaceuticals
  • Sagent
  • Spectrum Pharmaceuticals
  • Fresenius Kabi
  • GSK
  • Mylan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Melphalan Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Melphalan Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Melphalan Injection Market by Type
  6. 1.3.1 50mg/vial
  7. 1.3.2 10mg/vial
  8. 1.4 Global Melphalan Injection Market Size by Type
  9. 1.4.1 Global Melphalan Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Melphalan Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Melphalan Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Melphalan Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Melphalan Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Melphalan Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Melphalan Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Melphalan Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Melphalan Injection Industry Trends
  2. 2.2 Melphalan Injection Industry Drivers
  3. 2.3 Melphalan Injection Industry Opportunities and Challenges
  4. 2.4 Melphalan Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Melphalan Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Melphalan Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Melphalan Injection Price (2021-2026)
  4. 3.4 Global Melphalan Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Melphalan Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Melphalan Injection Company, Product Type & Application
  7. 3.7 Global Melphalan Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Melphalan Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Melphalan Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Melphalan Injection Tier 1, Tier 2, and Tier 3
4 Melphalan Injection Regional Status and Outlook
  1. 4.1 Global Melphalan Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Melphalan Injection Historic Market Size by Region
  3. 4.2.1 Global Melphalan Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Melphalan Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Melphalan Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Melphalan Injection Forecasted Market Size by Region
  7. 4.3.1 Global Melphalan Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Melphalan Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Melphalan Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Melphalan Injection by Application
  1. 5.1 Melphalan Injection Market by Application
  2. 5.1.1 Recovery Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.2 Global Melphalan Injection Market Size by Application
  6. 5.2.1 Global Melphalan Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Melphalan Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Melphalan Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Melphalan Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Melphalan Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Melphalan Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Melphalan Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Melphalan Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Athenex
  2. 6.1.1 Athenex Company Information
  3. 6.1.2 Athenex Business Overview
  4. 6.1.3 Athenex Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Athenex Melphalan Injection Product Portfolio
  6. 6.1.5 Athenex Recent Developments
  7. 6.2 Dr. Reddy's
  8. 6.2.1 Dr. Reddy's Company Information
  9. 6.2.2 Dr. Reddy's Business Overview
  10. 6.2.3 Dr. Reddy's Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dr. Reddy's Melphalan Injection Product Portfolio
  12. 6.2.5 Dr. Reddy's Recent Developments
  13. 6.3 Mediclone Biotech
  14. 6.3.1 Mediclone Biotech Company Information
  15. 6.3.2 Mediclone Biotech Business Overview
  16. 6.3.3 Mediclone Biotech Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mediclone Biotech Melphalan Injection Product Portfolio
  18. 6.3.5 Mediclone Biotech Recent Developments
  19. 6.4 Meitheal Pharmaceutical
  20. 6.4.1 Meitheal Pharmaceutical Company Information
  21. 6.4.2 Meitheal Pharmaceutical Business Overview
  22. 6.4.3 Meitheal Pharmaceutical Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Meitheal Pharmaceutical Melphalan Injection Product Portfolio
  24. 6.4.5 Meitheal Pharmaceutical Recent Developments
  25. 6.5 Par Pharmaceuticals
  26. 6.5.1 Par Pharmaceuticals Company Information
  27. 6.5.2 Par Pharmaceuticals Business Overview
  28. 6.5.3 Par Pharmaceuticals Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Par Pharmaceuticals Melphalan Injection Product Portfolio
  30. 6.5.5 Par Pharmaceuticals Recent Developments
  31. 6.6 Sagent
  32. 6.6.1 Sagent Company Information
  33. 6.6.2 Sagent Business Overview
  34. 6.6.3 Sagent Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sagent Melphalan Injection Product Portfolio
  36. 6.6.5 Sagent Recent Developments
  37. 6.7 Spectrum Pharmaceuticals
  38. 6.7.1 Spectrum Pharmaceuticals Company Information
  39. 6.7.2 Spectrum Pharmaceuticals Business Overview
  40. 6.7.3 Spectrum Pharmaceuticals Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Spectrum Pharmaceuticals Melphalan Injection Product Portfolio
  42. 6.7.5 Spectrum Pharmaceuticals Recent Developments
  43. 6.8 Fresenius Kabi
  44. 6.8.1 Fresenius Kabi Company Information
  45. 6.8.2 Fresenius Kabi Business Overview
  46. 6.8.3 Fresenius Kabi Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fresenius Kabi Melphalan Injection Product Portfolio
  48. 6.8.5 Fresenius Kabi Recent Developments
  49. 6.9 GSK
  50. 6.9.1 GSK Company Information
  51. 6.9.2 GSK Business Overview
  52. 6.9.3 GSK Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GSK Melphalan Injection Product Portfolio
  54. 6.9.5 GSK Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Melphalan Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Melphalan Injection Product Portfolio
  60. 6.10.5 Mylan Recent Developments
7 North America by Country
  1. 7.1 North America Melphalan Injection Sales by Country
  2. 7.1.1 North America Melphalan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Melphalan Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Melphalan Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Melphalan Injection Market Size by Country
  6. 7.2.1 North America Melphalan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Melphalan Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Melphalan Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Melphalan Injection Sales by Country
  2. 8.1.1 Europe Melphalan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Melphalan Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Melphalan Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Melphalan Injection Market Size by Country
  6. 8.2.1 Europe Melphalan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Melphalan Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Melphalan Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Melphalan Injection Sales by Country
  2. 9.1.1 Asia-Pacific Melphalan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Melphalan Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Melphalan Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Melphalan Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Melphalan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Melphalan Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Melphalan Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Melphalan Injection Sales by Country
  2. 10.1.1 South America Melphalan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Melphalan Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Melphalan Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Melphalan Injection Market Size by Country
  6. 10.2.1 South America Melphalan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Melphalan Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Melphalan Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Melphalan Injection Sales by Country
  2. 11.1.1 Middle East and Africa Melphalan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Melphalan Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Melphalan Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Melphalan Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Melphalan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Melphalan Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Melphalan Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Melphalan Injection Value Chain Analysis
  2. 12.1.1 Melphalan Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Melphalan Injection Production Mode & Process
  7. 12.2 Melphalan Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Melphalan Injection Distributors
  10. 12.2.3 Melphalan Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research